Vascular and glomerular manifestations of viral hepatitis B and C: a review

Seminars in Diagnostic Pathology

Volumn 26, Issue 2, 2009, Pages 116-121

  A Adeyi, Oyedele ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cryoglobulinemia; Glomerulonephritis; HBV; HCV; Polyarteritis; Vasculitis; Vasculopathy; Viral hepatitis

Indexed keywords

CARDIOLIPIN ANTIBODY; INTERFERON; PHOSPHOLIPID ANTIBODY;

ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL FEATURE; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; GLOMERULOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; THROMBOSIS; VASCULITIS; VIRUS HEPATITIS;

HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY GLOMERULUS; VASCULITIS;

EID: 70349510235     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2009.08.003     Document Type: Article

References (39)

1. Yu M.C., Yuan J.M., Govindarajan S., et al. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 14 (2000) 703-709
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11 (2004) 97-107
3. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6 (1999) 35-47
4. Mayo M.J. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci 325 (2003) 135-148
5. Pyrsopoulos N.T., and Reddy K.R. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep 3 (2001) 71-78
6. Cacoub P., Saadoun D., Bourliere M., et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 43 (2005) 764-770
7. Cacoub P., Poynard T., Ghillani P., et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum 42 (1999) 2204-2212
8. Musset L., Diemert M.C., Taibi F., et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 38 (1992) 798-802
9. Mascia M.T., Ferrari D., Campioli D., et al. Non HCV-related mixed cryoglobulinemia. Dig Liver Dis 39 (2007) S61-S64
10. Levo Y., Gorevic P.D., Kassab H.J., et al. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296 (1977) 1501-1504
11. Ferri C., Sebastiani M., Giuggioli D., et al. Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33 (2004) 355-374
12. Ferri C., Giuggioli D., Cazzato M., et al. HCV-related cryoglobulinemic vasculitis: An update on its etiopathogenesis and therapeutic strategies. Clin Exp Rheumatol 21 (2003) S78-S84
13. Zignego A.L., Ferri C., Giannelli F., et al. Prevalence of Bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 137 (2002) 571-580
14. Fornasieri A., Li M., Armelloni S., et al. Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice. Lab Invest 69 (1993) 531-540
15. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 3 (2008) 25
16. Ahmed M.S., Wong C.F., Shawki H., et al. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: A case report and review of literature. Clin Nephrol 69 (2008) 298-301
17. Janssen H.L., van Zonneveld M., van Nunen A.B., et al. Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome. Eur J Gastroenterol Hepatol 16 (2004) 801-807
18. Guillevin L., Lhote F., Cohen P., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74 (1995) 238-253
19. Guillevin L., Mahr A., Callard P., et al. Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84 (2005) 313-322
20. Scott D.G., Bacon P.A., Elliott P.J., et al. Systemic vasculitis in a district general hospital 1972-1980: Clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 51 (1982) 292-311
21. Mahr A., Guillevin L., Poissonnet M., et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate. Arthritis Rheum 51 (2004) 92-99
22. McMahon B.J., Heyward W.L., Templin D.W., et al. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: Clinical and epidemiologic features and long-term follow-up. Hepatology 9 (1989) 97-101
23. Ramos-Casals M., Jara L.J., Medina F., et al. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): Patterns of clinical and immunological expression in 180 cases. J Intern Med 257 (2005) 549-557
24. Trepo C., and Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis. J Autoimmun 16 (2001) 269-274
25. Wartelle-Bladou C., Lafon J., Trepo C., et al. Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection. J Hepatol 34 (2001) 774-779
26. Guillevin L., Lhote F., Gayraud M., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75 (1996) 17-28
27. Lightfoot Jr. R.W., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33 (1990) 1088-1093
28. Mason A., Theal J., Bain V., et al. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am J Gastroenterol 100 (2005) 972-976
29. Stokes M.B. Immune complex glomerulonephritis in patients with hepatitis C. Saudi J Kidney Dis Transpl 11 (2000) 396-404
30. Johnson R.J., and Couser W.G. Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37 (1990) 663-676
31. Prieto J., Yuste J.R., Beloqui O., et al. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 23 (1996) 199-204
32. Sene D., Piette J.C., and Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 7 (2008) 272-277
33. Watanabe T., Oono Y., Takeshita E., et al. A case of ANCA associated vasculitis induced by interferon therapy for HCV infection. Nippon Shokakibyo Gakkai Zasshi 105 (2008) 1787-1793
34. de Dios Garcia-Diaz J., Garcia-Sanchez M., Busteros J.I., et al. Polyarteritis nodosa after interferon treatment for chronic hepatitis C. J Clin Virol 32 (2005) 181-182
35. Yuste J.R., and Prieto J. Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences?. Eur J Gastroenterol Hepatol 15 (2003) 717-719
36. Zachou K., Liaskos C., Rigopoulou E., et al. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 119 (2006) 203-212
37. Elefsiniotis I.S., Diamantis I.D., Dourakis S.P., et al. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis. Eur J Gastroenterol Hepatol 15 (2003) 721-726
38. Matsumori A. Role of hepatitis C virus in cardiomyopathies. Ernst Schering Res Found Workshop 55 (2006) 99-120
39. Sanchez M.J., and Bergasa N.V. Hepatitis C associated cardiomyopathy: Potential pathogenic mechanisms and clinical implications. Med Sci Monit 14 (2008) RA55-RA63